{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 409083684
| IUPAC_name = ''N,N'',3-tris(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amide 2-oxide
| image = Trofosfamide.svg
| alt = Skeletal formula of trofosfamide
| width = 130
| image2 = Trofosfamide-3D-balls.png
| alt2 = Ball-and-stick model of the trofosfamide molecule
| width2 = 150

<!--Clinical data-->
| tradename = Ixoten
| Drugs.com = {{drugs.com|international|trofosfamide}}
| pregnancy_AU = <!-- A, B1, B2, B3, C, D, X -->
| pregnancy_US = <!-- A, B, C, D, X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_DE = Rx-only
| legal_status =
| routes_of_administration = [[Oral administration|By mouth]] (film-coated [[Tablet (pharmacy)|tablets]])

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 22089-22-1
| ATC_prefix = L01
| ATC_suffix = AA07
| ATC_supplemental =  
| PubChem = 65702
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = H64JRU6GJ0
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07252
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 462019
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 59129

<!--Chemical data-->
| chemical_formula =  
| C=9 | H=18 | Cl=3 | N=2 | O=2 | P=1 
| molecular_weight = 323.58 g/mol
| smiles = C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = UMKFEPPTGMDVMI-UHFFFAOYSA-N
}}

'''Trofosfamide''' ([[International Nonproprietary Name|INN]]) is a [[nitrogen mustard]] [[alkylating antineoplastic agent|alkylating agent]].

It is sometimes abbreviated "TRO".<ref name="pmid19099202">{{cite journal  |vauthors=Jahnke K, Thiel E, Bechrakis NE, etal |title=Ifosfamide or trofosfamide in patients with intraocular lymphoma |journal=J. Neurooncol. |volume= 93|issue= 2|pages= 213â€“7|date=December 2008 |pmid=19099202 |doi=10.1007/s11060-008-9761-8}}</ref>

==References==
{{reflist}}

{{Chemotherapeutic agents}}

[[Category:Organochlorides]]
[[Category:Oxazaphosphinans]]
[[Category:Phosphorodiamidates]]
[[Category:Nitrogen mustards]]

{{antineoplastic-drug-stub}}